LEADER 04188nam  2201321z- 450 
001 9910619464303321
005 20221025
010   $a3-0365-5333-9
035   $a(CKB)5670000000391631
035   $a(oapen)https://directory.doabooks.org/handle/20.500.12854/93240
035   $a(oapen)doab93240
035   $a(EXLCZ)995670000000391631
100   $a20202210d2022      |y         0
101 0 $aeng
135   $aurmn|---annan
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aAdvances in the Diagnosis and Treatment of Thyroid Carcinoma
210   $cMDPI - Multidisciplinary Digital Publishing Institute$d2022
215   $a1 online resource (286 p.)
311 08$a3-0365-5334-7 
330   $aThis reprint is related to the latest research in the field of thyroid surgery, including molecular and imaging diagnosis, surgical treatment, and the treatment of recurrent disease and advanced thyroid carcinoma.
606   $aMedicine and Nursing$2bicssc
606   $aOncology$2bicssc
610   $a18F-FDG-PET/CT
610   $aanaplastic thyroid cancer
610   $aangiogenesis process
610   $aangiogenic microenvironment
610   $aantiangiogenic therapy
610   $aautoimmune thyroid diseases
610   $abone metastasis
610   $acAMP
610   $aCarney complex
610   $acell cycle control pathways
610   $aclassification
610   $aclinical management
610   $acompanion diagnostics
610   $acomputer tomography
610   $aCONUT score
610   $acost-benefit analysis
610   $adifferentiated thyroid cancer
610   $aeconomics
610   $aEFVPTC
610   $afine-needle aspiration
610   $afluorescence-guided surgery
610   $afluorodeoxyglucose F18 (18F-FDG)
610   $aGal-3 expression
610   $agenetic landscape
610   $agenetically guided therapy
610   $ahistology
610   $ahypoparathyroidism
610   $aimmunohistochemical (IHC) analysis
610   $aimmunoPET
610   $aLenvatinib
610   $alobectomy
610   $alymph node metastases
610   $alymph node metastasis
610   $alymphocytic thyroiditis (LT)
610   $amagnetic resonance imaging
610   $amagnetic resonance imaging (MRI)
610   $amedical
610   $amedullary thyroid carcinoma
610   $ametastasectomy
610   $aminimal extrathyroidal extension
610   $amolecular imaging
610   $amultifocality
610   $anear-infrared autofluorescence
610   $aneoplasm metastasis
610   $aNIFTP
610   $aoperative extent
610   $apapillary thyroid cancer
610   $apapillary thyroid carcinoma
610   $aPKA
610   $apoorly thyroid cancer
610   $apositron emission tomography (PET)
610   $aprediction
610   $aPRKAR1A
610   $aprognosis
610   $aprognostic factors
610   $aproliferation pathways
610   $aprophylactic central lymph node dissection
610   $aradioactive iodine therapy
610   $aradioiodine refractory
610   $aradiomics
610   $arecurrence
610   $aRET
610   $astereotactic radiosurgery
610   $atheranostics
610   $atherapeutic target
610   $athyroid cancer
610   $athyroid carcinoma
610   $athyroid neoplasms
610   $athyroid nodule
610   $athyroid surgery
610   $aTNM
610   $atumor behavior
610   $atumor microenvironment
610   $atyrosine kinase inhibitors
610   $aultrasound
610   $aultrasound imaging
610   $avariants of uncertain significance
610   $avascular invasion
615  7$aMedicine and Nursing
615  7$aOncology
700   $aMedas$b Fabio$4edt$01315237
702   $aAlesina$b Pier Francesco$4edt
702   $aMedas$b Fabio$4oth
702   $aAlesina$b Pier Francesco$4oth
906   $aBOOK
912   $a9910619464303321
996   $aAdvances in the Diagnosis and Treatment of Thyroid Carcinoma$93032284
997   $aUNINA